1 week ago
2
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 successful BioAge betwixt September 26, 2024 and January 7, 2025 and would similar to sermon your ineligible rights, telephone Faruqi & Faruqi spouse Josh Wilson straight at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You whitethorn besides click present for further information]
New York, New York--(Newsfile Corp. - January 11, 2025) - Faruqi & Faruqi, LLP, a starring nationalist securities instrumentality firm, is investigating imaginable claims against BioAge Labs, Inc. ("BioAge" oregon the "Company") (NASDAQ: BIOA) and reminds investors of the March 10, 2025 deadline to question the relation of pb plaintiff successful a national securities people enactment that has been filed against the Company.
Faruqi & Faruqi is simply a starring nationalist securities instrumentality steadfast with offices successful New York, Pennsylvania, California and Georgia. The steadfast has recovered hundreds of millions of dollars for investors since its founding successful 1995. See www.faruqilaw.com.
As elaborate below, the ailment alleges that the Company and its executives violated national securities laws by making mendacious and/or misleading accusation concerning its STRIDES Phase 2 objective trial.
BioAge completed its archetypal nationalist offering connected September 27, 2024, selling 12.65 cardinal shares astatine $18 per share, which included the workout successful afloat by the underwriters of their enactment to acquisition 1.65 cardinal further shares.
However, little than 3 months later, connected December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES Phase 2 survey of its investigational cause campaigner azelaprag aft liver transaminitis was observed successful immoderate subjects receiving azelapgrag. An expert reported connected the announcement, noting that the quality was astonishing that liver tox ne'er appeared crossed 8 Phase 1 studies conducted antecedently by BioAge.
In effect to the news, BioAge's banal terms declined from $20.09 per stock connected December 6, 2024 to $4.65 per stock connected December 9, 2024.
The court-appointed pb plaintiff is the capitalist with the largest fiscal involvement successful the alleviation sought by the people who is capable and emblematic of people members who directs and oversees the litigation connected behalf of the putative class. Any subordinate of the putative people whitethorn determination the Court to service arsenic pb plaintiff done counsel of their choice, oregon whitethorn take to bash thing and stay an absent people member. Your quality to stock successful immoderate betterment is not affected by the determination to service arsenic a pb plaintiff oregon not.
Faruqi & Faruqi, LLP besides encourages anyone with accusation regarding BioAge's behaviour to interaction the firm, including whistleblowers, erstwhile employees, shareholders and others.
Attorney Advertising. The instrumentality steadfast liable for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results bash not warrant oregon foretell a akin result with respect to immoderate aboriginal matter. We invited the accidental to sermon your peculiar case. All communications volition beryllium treated successful a confidential manner.
To presumption the root mentation of this property release, delight sojourn https://www.newsfilecorp.com/release/236722
.jpg)
English (US) ·